Both platforms serve as backbone infrastructure for remote work and software development, making these flaws particularly dangerous for business continuity.
The company posted a 14% year-on-year decline in consolidated net profit. Shares of pharma major Dr. Reddy’s Laboratories rose 4.8% to Rs 1,211 on the BSE in early trade on Thursday, even as the ...
Critical vulnerabilities in edge devices are continuing to be discovered by security researchers and rapidly targeted by ...
Dr Reddy’s Laboratories reported a 14% YoY drop in Q3 net profit to Rs 1,210 crore, even as revenue rose 4% to Rs 8,727 crore ...
Say goodbye to source maps and compilation delays. By treating types as whitespace, modern runtimes are unlocking a “no-build” TypeScript that keeps stack traces accurate and workflows clean.
Pharma major Dr Reddy's Laboratories (DRL) reported a 14 per cent year-on-year (Y-o-Y) drop in consolidated net profit to Rs 1,210 crore in the December quarter of FY 2025-26 (Q3FY26) on low sales of ...
Operating under the FDA's 503B pathway, the Apex facility will prioritize the production of generic shortage-listed ...
Deep dive into tenant isolation strategies for SaaS. Learn about infrastructure patterns, data partitioning, and ...
Zoom and GitLab have released security updates to resolve a number of security vulnerabilities that could result in denial-of ...
The 5.5mL version of the BD Neopak XtraFlow syringe is fully compatible with Ypsomed’s YpsoMate 5.5 autoinjector platform.
Developer productivity depends on flow: the state where engineers maintain focus, context and momentum. When issues are discovered late in the development process – after commits, code reviews or CI ...
The big difference between aiFWall and traditional network firewalls is that this is a two way circular defense around the AI ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback